Semaglutide and Bone Fracture Risk: What People With Type 2 Diabetes Should Know 24th June 2026 by Living Diabetes Editorial An ENDO 2026 real-world study linked semaglutide with fewer bone fractures than several other weight-loss medicines in adults with type 2 diabetes. The finding is interesting, but it does not prove semaglutide prevents fractures.
Berobenatide VESPER Results: What Patients Should Know 11th June 2026 by Living Diabetes Editorial Phase 2b VESPER data suggest berobenatide may lower weight and A1C, but it remains investigational. Here is what patients should know.